PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PFIE vs. TSHA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PFIE and TSHA is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

PFIE vs. TSHA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Profire Energy, Inc. (PFIE) and Taysha Gene Therapies, Inc. (TSHA). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
52.10%
-32.21%
PFIE
TSHA

Key characteristics

Sharpe Ratio

PFIE:

0.59

TSHA:

0.02

Sortino Ratio

PFIE:

1.54

TSHA:

0.91

Omega Ratio

PFIE:

1.22

TSHA:

1.11

Calmar Ratio

PFIE:

0.56

TSHA:

0.02

Martin Ratio

PFIE:

2.57

TSHA:

0.05

Ulcer Index

PFIE:

16.61%

TSHA:

40.33%

Daily Std Dev

PFIE:

72.21%

TSHA:

110.93%

Max Drawdown

PFIE:

-88.74%

TSHA:

-98.14%

Current Drawdown

PFIE:

-56.06%

TSHA:

-95.28%

Fundamentals

Market Cap

PFIE:

$117.35M

TSHA:

$313.56M

EPS

PFIE:

$0.19

TSHA:

$0.63

PE Ratio

PFIE:

13.37

TSHA:

2.43

Total Revenue (TTM)

PFIE:

$46.00M

TSHA:

$6.31M

Gross Profit (TTM)

PFIE:

$22.60M

TSHA:

$5.69M

EBITDA (TTM)

PFIE:

$8.13M

TSHA:

-$69.51M

Returns By Period


PFIE

YTD

0.00%

1M

-0.20%

6M

62.82%

1Y

59.75%

5Y*

11.92%

10Y*

1.10%

TSHA

YTD

-13.29%

1M

-14.29%

6M

-33.33%

1Y

-6.25%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PFIE vs. TSHA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PFIE
The Risk-Adjusted Performance Rank of PFIE is 7171
Overall Rank
The Sharpe Ratio Rank of PFIE is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of PFIE is 7272
Sortino Ratio Rank
The Omega Ratio Rank of PFIE is 7474
Omega Ratio Rank
The Calmar Ratio Rank of PFIE is 6969
Calmar Ratio Rank
The Martin Ratio Rank of PFIE is 7070
Martin Ratio Rank

TSHA
The Risk-Adjusted Performance Rank of TSHA is 5050
Overall Rank
The Sharpe Ratio Rank of TSHA is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of TSHA is 5757
Sortino Ratio Rank
The Omega Ratio Rank of TSHA is 5555
Omega Ratio Rank
The Calmar Ratio Rank of TSHA is 4646
Calmar Ratio Rank
The Martin Ratio Rank of TSHA is 4747
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PFIE vs. TSHA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Profire Energy, Inc. (PFIE) and Taysha Gene Therapies, Inc. (TSHA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PFIE, currently valued at 0.85, compared to the broader market-2.000.002.000.850.02
The chart of Sortino ratio for PFIE, currently valued at 1.87, compared to the broader market-4.00-2.000.002.004.001.870.91
The chart of Omega ratio for PFIE, currently valued at 1.28, compared to the broader market0.501.001.502.001.281.11
The chart of Calmar ratio for PFIE, currently valued at 1.09, compared to the broader market0.002.004.006.001.090.02
The chart of Martin ratio for PFIE, currently valued at 3.91, compared to the broader market-20.00-10.000.0010.0020.003.910.05
PFIE
TSHA

The current PFIE Sharpe Ratio is 0.59, which is higher than the TSHA Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of PFIE and TSHA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
0.85
0.02
PFIE
TSHA

Dividends

PFIE vs. TSHA - Dividend Comparison

Neither PFIE nor TSHA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PFIE vs. TSHA - Drawdown Comparison

The maximum PFIE drawdown since its inception was -88.74%, smaller than the maximum TSHA drawdown of -98.14%. Use the drawdown chart below to compare losses from any high point for PFIE and TSHA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-17.67%
-95.28%
PFIE
TSHA

Volatility

PFIE vs. TSHA - Volatility Comparison

The current volatility for Profire Energy, Inc. (PFIE) is 0.49%, while Taysha Gene Therapies, Inc. (TSHA) has a volatility of 19.13%. This indicates that PFIE experiences smaller price fluctuations and is considered to be less risky than TSHA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%AugustSeptemberOctoberNovemberDecember2025
0.49%
19.13%
PFIE
TSHA

Financials

PFIE vs. TSHA - Financials Comparison

This section allows you to compare key financial metrics between Profire Energy, Inc. and Taysha Gene Therapies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab